22.04.2009 20:05:00
|
Lam Research Corporation Announces Financial Results for the Quarter Ended March 29, 2009
Lam Research Corporation (NASDAQ:LRCX) highlights for the March 2009 quarter were:
(in thousands, except per share data and percentages) | ||||||||
? | Revenue: | $ |
174,412 |
|||||
U.S. GAAP | Ongoing | |||||||
? | Operating Margin: | -111.9 | % | -47.1 | % | |||
? | Net Loss: | $ | (198,359 | ) | $ | (89,771 | ) | |
? | Diluted EPS: | $ | (1.58 | ) | $ | (0.71 | ) |
Lam Research Corporation today announced financial results for the quarter ended March 29, 2009. Revenue for the period was $174.4 million, gross margin was $36.5 million and net loss was $(198.4) million, or $(1.58) per diluted share, compared to revenue of $283.4 million, gross margin of $101.4 million and net loss of $(24.2) million, or $(0.19) per diluted share, for the December 2008 quarter. Shipments for the March 2009 quarter were $159 million compared to $226 million during the December 2008 quarter.
As a result of a combination of factors, including the current economic environment, a sustained decline in the Company’s market valuation and a decline in the Company’s operating results, the Company has concluded that the fair value of its Clean Product Group has been reduced below its carrying value. As a result, the Company has recorded a non-cash goodwill impairment charge of approximately $89.1 million during the March 2009 quarter. The goodwill impairment charge is based on the Company’s current best estimate. If there is a change to this estimate, it will be reflected in the March 2009 quarter financial statements included in the Company’s quarterly report on Form 10-Q for the quarter ended March 29, 2009, which is anticipated to be filed on or before May 8, 2009.
The Company’s ongoing results for the March 2009 quarter exclude certain costs for previously announced restructuring activities and asset impairments, the goodwill impairment charge noted above, a net tax expense for a change in state tax law, a net tax expense and an exchange rate gain associated with the Company’s accelerated tax planning strategy, an investment impairment, and interest on the tax liability associated with the outcome of the Company’s previously disclosed voluntary internal stock option review. The Company’s ongoing results for the December 2008 quarter excluded certain costs for restructuring activities and asset impairments, a net tax benefit related to the renewal of the research and development tax credit, net tax expense on resolution of certain tax items, one-time costs associated with the restructuring of an employee benefit plan, a net tax benefit and an exchange rate loss associated with the Company’s accelerated tax planning strategy, and interest on the tax liability associated with the outcome of the Company’s previously disclosed voluntary internal stock option review. Management uses the presentation of ongoing gross margin, ongoing operating expenses, ongoing operating loss, ongoing net loss, and ongoing net loss per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing ongoing business trends and comparing performance to prior periods, and enhances the investor’s ability to view the Company’s results from management’s perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company’s web site.
Ongoing net loss was $(89.8) million, or $(0.71) per diluted share in the March 2009 quarter compared to ongoing net loss of $(11.7) million, or $(0.09) per diluted share, for the December 2008 quarter. Ongoing gross margin for the March 2009 quarter was $46.7 million or 26.8%, compared to ongoing gross margin of $109.1 million, or 38.5%, for the December 2008 quarter. The sequential decline in gross margin was primarily due to lower manufacturing and field utilization levels resulting from reduced business activity as well as product mix. Ongoing operating expenses for the March 2009 quarter increased to $128.9 million compared with the December 2008 quarter of $126.5 million. This increase was driven by additional accounts receivables reserves for specific distressed customers, partially offset by a reduction in employee expenses as a result of restructuring and other cost-savings activities.
The geographic distribution of shipments and revenue during the March 2009 quarter is shown in the following table:
Region | Shipments | Revenue | ||
North America | 16% | 15% | ||
Europe | 17% | 14% | ||
Japan | 27% | 24% | ||
Korea | 17% | 19% | ||
Taiwan | 15% | 20% | ||
Asia Pacific | 8% | 8% |
Cash and cash equivalents, short-term investments and restricted cash and investments balances were $806.4 million at the end of the March 2009 quarter, compared to $1.1 billion at the end of the December 2008 quarter. The Company paid the outstanding principal balance of $237.5 million of its long-term debt during the March 2009 quarter. Cash flows from operating activities were approximately $(24.2) million during the March 2009 quarter. Deferred revenue and deferred profit balances at the end of the March 2009 quarter were $43.7 million and $36.1 million, respectively. Our deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $7.5 million as of March 29, 2009.
"We are developing next-generation technology solutions alongside our customers and are continuing to win new application tool selection decisions in both etch and clean at the leading-edge technology nodes. We are fortunate to have a strong balance sheet with sufficient cash to: continue making investments in key R&D programs, place next-generation tools at customer sites for joint development projects and evaluations, and deploy inventories to meet short-term shipment requirements as well as respond to any future increases in demand,” said Steve Newberry, Lam’s president and chief executive officer. "Our focus remains on investing in strategic opportunities while aggressively managing the cost structure and cash expenditures of the Company. This will enhance our ability to meet the expectations and needs of our customers and strengthen our market position for the next upturn,” Newberry concluded.
Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to our estimate of the goodwill impairment charge, the anticipated revenue from shipments to Japanese customers, the potential uses of our cash and other assets, and our ability to develop next generation technology solutions, win new application tool selection decisions in both etch and clean, continue to be able to invest in research and development, place next-generation tools at customer sites, be successful in deploying our inventory to meet demand, focus on and invest in strategic opportunities, be successful in managing our cost structure and cash expenditures, meet the expectations and needs of our customers, and strengthen our market position. Some factors that may affect these forward-looking statements include: difficult business conditions in the semiconductor industry and the overall economy and the efficacy of our plans for reacting to those conditions, factors that tend to make our quarterly results more volatile (such as exchange rate fluctuations), changing customer demands, the actions of our competitors, and the challenges presented by the development and marketing of our new products and the integration of acquired businesses and technologies into our existing business. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 29, 2008, and Form 10-Q for the quarters ended September 28, 2008 and December 28, 2008, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.
Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world’s semiconductor industry. Lam’s common stock trades on The Nasdaq Global Select MarketSM under the symbol LRCX. Lam is a NASDAQ-100® company. For more information, visit www.lamresearch.com.
Consolidated Financial Tables Follow
LAM RESEARCH CORPORATION | ||||||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||||
(in thousands, except per share data and percentages) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
March 29, | December 28, | March 30, | March 29, | March 30, | ||||||||||||||||
2009 | 2008 | 2008 | 2009 | 2008 | ||||||||||||||||
Total revenue | $ | 174,412 | $ | 283,409 | $ | 613,810 | $ | 898,182 | $ | 1,908,751 | ||||||||||
Cost of goods sold | 127,680 | 174,329 | 320,201 | 556,212 | 963,594 | |||||||||||||||
Cost of goods sold - 409A expense | - | - | 6,401 | - | 6,401 | |||||||||||||||
Cost of goods sold - restructuring and asset impairments | 10,217 | 7,728 | - | 20,993 | - | |||||||||||||||
Total cost of goods sold | 137,897 | 182,057 | 326,602 | 577,205 | 969,995 | |||||||||||||||
Gross margin | 36,515 | 101,352 | 287,208 | 320,977 | 938,756 | |||||||||||||||
Gross margin as a percent of revenue | 20.9 | % | 35.8 | % | 46.8 | % | 35.7 | % | 49.2 | % | ||||||||||
Research and development | 70,434 | 68,781 | 80,576 | 220,778 | 237,107 | |||||||||||||||
Selling, general and administrative | 58,515 | 59,842 | 74,491 | 185,813 | 210,288 | |||||||||||||||
Goodwill impairment | 89,076 | - | - | 89,076 | - | |||||||||||||||
Restructuring and asset impairments | 13,028 | 10,121 | - | 39,117 | - | |||||||||||||||
409A expense | 646 | - | 43,784 | 2,250 | 43,784 | |||||||||||||||
In-process research and development | - | - | 2,074 | - | 2,074 | |||||||||||||||
Total operating expenses | 231,699 | 138,744 | 200,925 | 537,034 | 493,253 | |||||||||||||||
Operating income (loss) | (195,184 | ) | (37,392 | ) | 86,283 | (216,057 | ) | 445,503 | ||||||||||||
Operating margin as a percent of revenue | -111.9 | % | -13.2 | % | 14.1 | % | -24.1 | % | 23.3 | % | ||||||||||
Other income (expense), net | 13,497 | (7,233 | ) | 49,605 | 15,281 | 57,201 | ||||||||||||||
Income (loss) before income taxes | (181,687 | ) | (44,625 | ) | 135,888 | (200,776 | ) | 502,704 | ||||||||||||
Income tax expense (benefit) | 16,672 | (20,453 | ) | 32,364 | 12,882 | 135,533 | ||||||||||||||
Net income (loss) | $ | (198,359 | ) | $ | (24,172 | ) | $ | 103,524 | $ | (213,658 | ) | $ | 367,171 | |||||||
Net income (loss) per share: | ||||||||||||||||||||
Basic net income (loss) per share | $ | (1.58 | ) | $ | (0.19 | ) | $ | 0.83 | $ | (1.70 | ) | $ | 2.95 | |||||||
Diluted net income (loss) per share | $ | (1.58 | ) | $ | (0.19 | ) | $ | 0.82 | $ | (1.70 | ) | $ | 2.90 | |||||||
Number of shares used in per share calculations: | ||||||||||||||||||||
Basic | 125,566 | 125,084 | 124,768 | 125,368 | 124,509 | |||||||||||||||
Diluted | 125,566 | 125,084 | 126,549 | 125,368 | 126,531 |
LAM RESEARCH CORPORATION | ||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(in thousands) | ||||||||||
March 29, | December 28, | June 29, | ||||||||
2009 | 2008 | 2008 | ||||||||
(unaudited) | (unaudited) | (1) | ||||||||
ASSETS | ||||||||||
Cash and cash equivalents | $ | 374,648 | $ | 652,913 | $ | 732,537 | ||||
Short-term investments | 248,500 | 297,399 | 326,199 | |||||||
Accounts receivable, net | 196,842 | 290,565 | 412,356 | |||||||
Inventories | 260,667 | 269,959 | 282,218 | |||||||
Deferred income taxes | 90,541 | 93,002 | 96,748 | |||||||
Other current assets | 82,273 | 56,648 | 67,649 | |||||||
Total current assets |
1,253,471 | 1,660,486 | 1,917,707 | |||||||
Property and equipment, net | 225,864 | 233,250 | 235,735 | |||||||
Restricted cash and investments | 183,277 | 168,405 | 146,072 | |||||||
Deferred income taxes | 15,281 | 25,836 | 19,793 | |||||||
Goodwill and intangible assets | 268,249 | 371,987 | 403,187 | |||||||
Other assets | 87,340 | 78,457 | 84,261 | |||||||
Total assets | $ | 2,033,482 | $ | 2,538,421 | $ | 2,806,755 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
Current liabilities | $ | 369,998 | $ | 446,412 | $ | 637,679 | ||||
Long-term debt and capital leases | $ | 39,943 | $ | 257,135 | $ | 276,121 | ||||
Income taxes payable | 99,807 | 92,382 | 85,611 | |||||||
Other long-term liabilities | 20,476 | 21,300 | 23,400 | |||||||
Minority interests | - | - | 5,347 | |||||||
Stockholders' equity | 1,503,258 | 1,721,192 | 1,778,597 | |||||||
Total liabilities and stockholders' equity | $ | 2,033,482 | $ | 2,538,421 | $ | 2,806,755 | ||||
1 Derived from audited financial statements |
LAM RESEARCH CORPORATION | ||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||||||||
(in thousands) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||
March 29, | December 28, | March 30, | March 29, | March 30, | ||||||||||||||||
2009 | 2008 | 2008 | 2009 | 2008 | ||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||||||||||
Net income (loss) | $ | (198,359 | ) | $ | (24,172 | ) | $ | 103,524 | $ | (213,658 | ) | $ | 367,171 | |||||||
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |
||||||||||||||||||||
Depreciation and amortization | 19,650 | 17,177 | 12,914 | 54,723 | 35,477 | |||||||||||||||
Deferred income taxes | 12,929 | 10,110 | (11,995 | ) | 10,632 | (22,009 | ) | |||||||||||||
Equity-based compensation expense | 10,227 | 14,049 | 10,272 | 39,684 | 30,887 | |||||||||||||||
Income tax benefit on equity-based compensation plans | (11,115 | ) | (7,045 | ) | (520 | ) | (13,121 | ) | 56,657 | |||||||||||
Excess tax benefit on equity-based compensation plans | 7,027 | 3,752 | 401 | 6,510 | (37,238 | ) | ||||||||||||||
Net gain on settlement of call option | - | - | (40,864 | ) | - | (33,694 | ) | |||||||||||||
Goodwill impairment | 89,076 | - | - | 89,076 | - | |||||||||||||||
Restructuring and asset impairments | 23,245 | 17,849 | - | 60,110 | - | |||||||||||||||
Other, net | 953 | 3,200 | (7,013 | ) | 6,818 | (2,867 | ) | |||||||||||||
Changes in operating asset accounts | 22,215 | (73,909 | ) | 79,266 | (60,783 | ) | (4,512 | ) | ||||||||||||
Net cash provided by (used for) operating activities | (24,152 | ) | (38,989 | ) | 145,985 | (20,009 | ) | 389,872 | ||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||||||||||
Capital expenditures and intangible assets | (10,866 | ) | (12,417 | ) | (19,291 | ) | (38,434 | ) | (57,852 | ) | ||||||||||
Acquisitions of businesses, net of cash acquired | (11,706 | ) | (8,763 | ) | (473,408 | ) | (22,896 | ) | (475,656 | ) | ||||||||||
Net sales (purchases) of available-for-sale securities | 33,961 | 39,767 | 83,201 | 80,708 | 51,316 | |||||||||||||||
Purchase of call option | - | - | (3,227 | ) | - | (13,506 | ) | |||||||||||||
Proceeds from settlement of call option | - | - | 46,962 | 46,962 | ||||||||||||||||
Purchases of other investments | - | - | - | - | (4,560 | ) | ||||||||||||||
Other | (8,375 | ) | (2,000 | ) | - | (10,375 | ) | - | ||||||||||||
Transfer of restricted cash and investments | 558 | (32,178 | ) | (688 | ) | (47,748 | ) | (1,762 | ) | |||||||||||
Net cash provided by (used for) investing activities | 3,572 | (15,591 | ) | (366,451 | ) | (38,745 | ) | (455,058 | ) | |||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||||||||||
Principal payments on long-term debt and capital lease obligations | (239,703 | ) | (13,060 | ) | (250,114 | ) | (255,136 | ) | (250,214 | ) | ||||||||||
Net proceeds from issuance of long-term debt | - | 515 | 250,000 | 625 | 250,000 | |||||||||||||||
Excess tax benefit on equity-based compensation plans | (7,027 | ) | (3,752 | ) | (401 | ) | (6,510 | ) | 37,238 | |||||||||||
Treasury stock purchases | (546 | ) | (24,448 | ) | (737 | ) | (27,749 | ) | (10,962 | ) | ||||||||||
Reissuances of treasury stock | 5,942 | - | - | 13,526 | 7,301 | |||||||||||||||
Proceeds from issuance of common stock | 1,283 | 1,294 | - | 5,727 | 10,106 | |||||||||||||||
Net cash provided by (used for) financing activities | (240,051 | ) | (39,451 | ) | (1,252 | ) | (269,517 | ) | 43,469 | |||||||||||
Effect of exchange rate changes on cash | (17,634 | ) | 1,512 | (1,984 | ) | (29,618 | ) | 103 | ||||||||||||
Net decrease in cash and cash equivalents | (278,265 | ) | (92,519 | ) | (223,702 | ) | (357,889 | ) | (21,614 | ) | ||||||||||
Cash and cash equivalents at beginning of period | 652,913 | 745,432 | 776,055 | 732,537 | 573,967 | |||||||||||||||
Cash and cash equivalents at end of period | $ | 374,648 | $ | 652,913 | $ | 552,353 | $ | 374,648 | $ | 552,353 |
Reconciliation of U.S. GAAP Net Loss to Ongoing Net Loss | ||||||||
(in thousands, except per share data) | ||||||||
Three Months Ended | Three Months Ended | |||||||
March 29, | December 28, | |||||||
2009 | 2008 | |||||||
U.S. GAAP net loss | $ | (198,359 | ) | $ | (24,172 | ) | ||
Pre-tax non-ongoing items: | ||||||||
Goodwill impairment - operating expenses | 89,076 | - | ||||||
Restructuring and asset impairments - cost of goods sold | 10,217 | 7,728 | ||||||
Restructuring and asset impairments - operating expenses | 13,028 | 10,121 | ||||||
Restructuring of employee benefit plan - operating expenses | - | 1,300 | ||||||
Voluntary internal stock option review - operating expenses | 646 | 843 | ||||||
Impairment of investment - other income (expense), net | 1,543 | - | ||||||
Exchange rate (gain) loss associated with accelerated tax planning strategy - other income (expense), net | (6,674 | ) | 7,569 | |||||
Net tax benefit on non-ongoing items | (5,506 | ) | (7,375 | ) | ||||
Net tax benefit on renewal of R&D tax credit | - | (5,751 | ) | |||||
Net tax expense on resolution of certain tax matters | - | 1,396 | ||||||
Net tax expense on change in state tax law | 5,244 | - | ||||||
Net tax expense (benefit) on accelerated tax planning strategy | 1,014 | (3,407 | ) | |||||
Ongoing net loss | $ | (89,771 | ) | $ | (11,748 | ) | ||
Ongoing net loss per diluted share | $ | (0.71 | ) | $ | (0.09 | ) | ||
Number of shares used for diluted per share calculation | 125,566 | 125,084 | ||||||
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Loss to Ongoing Gross Margin, Operating Expenses and Operating Loss | ||||||||
(in thousands, except percentages) | ||||||||
Three Months Ended | Three Months Ended | |||||||
March 29, | December 28, | |||||||
2009 | 2008 | |||||||
U.S. GAAP gross margin | $ | 36,515 | $ | 101,352 | ||||
Pre-tax non-ongoing items: | ||||||||
Restructuring and asset impairments - cost of goods sold | 10,217 | 7,728 | ||||||
Ongoing gross margin | $ | 46,732 | $ | 109,080 | ||||
U.S. GAAP gross margin as a percent of revenue |
20.9% |
|
35.8% |
|
||||
Ongoing gross margin as a percent of revenue |
26.8% |
|
38.5% |
|
||||
U.S. GAAP operating expenses | $ | 231,699 | $ | 138,744 | ||||
Pre-tax non-ongoing items: | ||||||||
Goodwill impairment - operating expenses | (89,076 | ) | - | |||||
Restructuring and asset impairments - operating expenses | (13,028 | ) | (10,121 | ) | ||||
Restructuring of employee benefit plan - operating expenses | - | (1,300 | ) | |||||
Voluntary internal stock option review - operating expenses | (646 | ) | (843 | ) | ||||
Ongoing operating expenses | $ | 128,949 | $ | 126,480 | ||||
Ongoing operating loss | $ | (82,217 | ) | $ | (17,400 | ) | ||
Ongoing operating loss as a percent of revenue | -47.1 | % | -6.1 | % |
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lam Research Corp.mehr Nachrichten
03.10.24 |
NASDAQ-Handel NASDAQ 100 sackt schlussendlich ab (finanzen.at) | |
03.10.24 |
NASDAQ Composite Index-Papier Lam Research-Aktie: So viel hätte eine Investition in Lam Research von vor einem Jahr abgeworfen (finanzen.at) | |
02.10.24 |
Aufschläge in New York: nachmittags Pluszeichen im S&P 500 (finanzen.at) | |
02.10.24 |
NASDAQ 100-Handel aktuell: NASDAQ 100 zeigt sich nachmittags fester (finanzen.at) | |
02.10.24 |
NASDAQ 100 aktuell: NASDAQ 100 mit Zuschlägen (finanzen.at) | |
02.10.24 |
Optimismus in New York: S&P 500 fester (finanzen.at) | |
27.09.24 |
Handel in New York: NASDAQ 100 fällt am Freitagnachmittag (finanzen.at) | |
27.09.24 |
NASDAQ-Handel NASDAQ 100 am Freitagmittag leichter (finanzen.at) |
Analysen zu Lam Research Corp.mehr Analysen
Aktien in diesem Artikel
Lam Research Corp. | 720,00 | -0,54% |
Indizes in diesem Artikel
NASDAQ Comp. | 18 974,70 | 0,01% | |
NASDAQ 100 | 20 738,13 | -0,01% | |
S&P 400 MidCap | 1 854,40 | -0,45% |